SetPoint Medical Receives $15,000,000 Series C Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c97d2102-2400-4168-b601-de0db24a4f9a
Date
9/8/2015
Company Name
SetPoint Medical
Mailing Address
28368 Constellation Rd. Valencia, CA 91355 USA
Company Description
SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn’s Disease. The company’s scientific platform is based on the Inflammatory Reflex—the natural mechanism by which the central nervous system regulates the immune system. SetPoint co-founder Kevin Tracey discovered the Inflammatory Reflex pathway, publishing his findings in the journal Nature in May 2000.
Website
http://www.setpointmedical.com
Transaction Type
Venture Equity
Transaction Amount
$15,000,000
Transaction Round
Series C
Proceeds Purposes
Proceeds from the financing will be used to support the company’s clinical trials to assess safety and efficacy of its bioelectronic therapy in rheumatoid arthritis (RA) and Crohn’s Disease, and to help advance the therapy toward commercialization.
M&A Terms
Venture Investor
Undisclosed